Risk factors for Non-Hodgkin's lymphoma in autoimmune disease: a large database analysis

Area of Science:

• Oncology
• Immunology
• Epidemiology

Background:

• Immune dysregulation in autoimmune diseases (ADs) is linked to an increased risk of Non-Hodgkin's lymphoma (NHL).
• Mechanisms underlying this association require further elucidation.
• Patients with ADs may experience poorer NHL prognosis compared to those without ADs.

Purpose of the Study:

• To identify clinical and demographic factors associated with NHL development in patients with ADs.
• To compare risk factors for NHL in patients with and without underlying ADs.

Main Methods:

• Retrospective analysis of the National Inpatient Sample (NIS) database from 2016-2020.
• Inclusion of adult patients (>18 years) diagnosed with NHL.
• Comparison of two cohorts: patients with ADs and patients without ADs, analyzing adjusted odds ratios (aOR) for risk factors.

Main Results:

• NHL prevalence was 0.9% in autoimmune cases and 0.7% in non-autoimmune cases.
• Factors increasing NHL risk in AD patients included prior chemotherapy/radiation, family history of lymphoid malignancy, HIV, advanced age (60-69), Asian/Pacific Islander ethnicity, and viral hepatitis.
• The study highlights lesser-known risk factors, including patient characteristics and comorbidities.

Conclusions:

• Specific patient characteristics and comorbidities significantly influence NHL risk in individuals with autoimmune diseases.
• Understanding these interplay factors is crucial for risk stratification and management of NHL in AD patients.
• Further research is warranted to explore the underlying mechanisms connecting ADs, traditional NHL risk factors, and autoimmunity.